Similar articles

• Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

  Pinheiro RGR, Coutinho AJ, Pinheiro M, Neves AR. Pinheiro RGR, et al. Int J Mol Sci. 2021 Oct 28;22(21):11654. doi: 10.3390/ijms222111654. Int J Mol Sci. 2021. PMID: 34769082 Free PMC article. Review.
• Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.

  Rabiei M, Kashanian S, Samavati SS, Jamasb S, McInnes SJP. Rabiei M, et al. Curr Pharm Biotechnol. 2020;21(5):374-383. doi: 10.2174/1389201020666191203094057. Curr Pharm Biotechnol. 2020. PMID: 31793421 Review.
• Recent progress of drug nanoformulations targeting to brain.

  Khan AR, Yang X, Fu M, Zhai G. Khan AR, et al. J Control Release. 2018 Dec 10;291:37-64. doi: 10.1016/j.jconrel.2018.10.004. Epub 2018 Oct 9. J Control Release. 2018. PMID: 30308256 Review.
• Noninvasive nanoparticle strategies for brain tumor targeting.

  Sun C, Ding Y, Zhou L, Shi D, Sun L, Webster TJ, Shen Y. Sun C, et al. Nanomedicine. 2017 Nov;13(8):2605-2621. doi: 10.1016/j.nano.2017.07.009. Epub 2017 Jul 27. Nanomedicine. 2017. PMID: 28756093 Review.
• Nano carriers for drug transport across the blood-brain barrier.

  Li X, Tsibouklis J, Weng T, Zhang B, Yin G, Feng G, Cui Y, Savina IN, Mikhalovska LI, Sandeman SR, Howel CA, Mikhalovsky SV. Li X, et al. J Drug Target. 2017 Jan;25(1):17-28. doi: 10.1080/1061186X.2016.1184272. Epub 2016 May 19. J Drug Target. 2017. PMID: 27126681 Review.